NATCO Pharma Limited Investment Presentation – Proposed Investment Transaction Summary Target Geography Proposed Shareholding SOUTH AFRICA The Bidvest Group Limited 64.25% NATCO Pharma Limited 35.75% Price per share Cost to NATCO Transaction Cost Revenue in US$Mn EV/EBITDA Revenue Multiple ZAR 75 US$ 4.271 ZAR 4 Bn US$226 Mn1 ₹ 2,000 Cr ~US$ 10 Mn 484 507 536 262 FY22 FY23 FY24 H1FY25 7.83 1.12 1:Exchange Rate : 1 USD = 17.54 ZAR, 1 USD = ₹86.39 All other US$ conversions are at 1 USD = 18 ZAR Multiples ar ...